Citations (183)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (17)
Shiho Ito, Kyoko Miwa, Chiharu Hattori, Tetsuo Aida, Yoshimi Tsuchiya & Kazuhiko Mori. (2021) Highly sensitive in vitro cytokine release assay incorporating high-density preculture. Journal of Immunotoxicology 18:1, pages 136-143.
Read now
Read now
Macarena C Cáceres, Jorge Guerrero-Martín, Demetrio Pérez-Civantos, Patricia Palomo-López, Juan Ignacio Delgado-Mingorance & Noelia Durán-Gómez. (2019) The importance of early identification of infusion-related reactions to monoclonal antibodies. Therapeutics and Clinical Risk Management 15, pages 965-977.
Read now
Read now
Lykke Boysen, Brian Lauritzen, Birgitte Martine Viuff, Jens Lykkesfeldt & Lone Hummelshøj Landsy. (2019) An ELISA for detection of complement-bound circulating immune complexes in mice. Journal of Immunotoxicology 16:1, pages 82-86.
Read now
Read now
Micael Karlberg, Moritz von Stosch & Jarka Glassey. (2018) Exploiting mAb structure characteristics for a directed QbD implementation in early process development. Critical Reviews in Biotechnology 38:6, pages 957-970.
Read now
Read now
Brendon Frank, Yu-Ling Wei, Kyung-Hoon Kim, Abraham Guerrero, Hervé Lebrec, Mercedesz Balazs & Xiaoting Wang. (2018) Development of a BiTE®-mediated CD8+ cytotoxic T-lymphocyte activity assay to assess immunomodulatory potential of drug candidates in Cynomolgus macaque. Journal of Immunotoxicology 15:1, pages 119-125.
Read now
Read now
Xiaohua Zhu, Mohamed Badawi, Steven Pomeroy, Dhruvitkumar S. Sutaria, Zhiliang Xie, Alice Baek, Jinmai Jiang, Ola A. Elgamal, Xiaokui Mo, Krista La Perle, Jeffrey Chalmers, Thomas D. Schmittgen & Mitch A. Phelps. (2017) Comprehensive toxicity and immunogenicity studies reveal minimal effects in mice following sustained dosing of extracellular vesicles derived from HEK293T cells. Journal of Extracellular Vesicles 6:1.
Read now
Read now
Dheeraj S. Tomar, Li Li, Matthew P. Broulidakis, Nicholas G. Luksha, Christopher T. Burns, Satish K. Singh & Sandeep Kumar. (2017) In-silico prediction of concentration-dependent viscosity curves for monoclonal antibody solutions. mAbs 9:3, pages 476-489.
Read now
Read now
Ji Soo Kim, Sung Hwan Kim, ByoungOh Kwon & SeungSuh Hong. (2015) Comparison of immunogenicity test methods used in clinical studies of infliximab and its biosimilar (CT-P13). Expert Review of Clinical Immunology 11:sup1, pages 33-41.
Read now
Read now
François Curtin, Hervé Perron, Arno Kromminga, Hervé Porchet & Alois B Lang. (2015) Preclinical and early clinical development of GNbAC1, a humanized IgG4 monoclonal antibody targeting endogenous retroviral MSRV-Env protein. mAbs 7:1, pages 265-275.
Read now
Read now
Nicolas Poirier, Caroline Mary, Stephanie Le Bas-Bernardet, Veronique Daguin, Lyssia Belarif, Melanie Chevalier, Jeremy Hervouet, David Minault, Simon Ville, Vianney Charpy, Gilles Blancho & Bernard Vanhove. (2014) Advantages of Papio anubis for preclinical testing of immunotoxicity of candidate therapeutic antagonist antibodies targeting CD28. mAbs 6:3, pages 697-706.
Read now
Read now
Cris Kamperschroer, Lynn M. O’Donnell, Patricia A. Schneider, Dingzhou Li, Marc Roy, Timothy M. Coskran & Thomas T. Kawabata. (2014) Measuring T-cell responses against LCV and CMV in cynomolgus macaques using ELISPOT: Potential application to non-clinical testing of immunomodulatory therapeutics. Journal of Immunotoxicology 11:1, pages 35-43.
Read now
Read now
François Curtin & Hans-Peter Hartung. (2014) Novel therapeutic options for multiple sclerosis. Expert Review of Clinical Pharmacology 7:1, pages 91-104.
Read now
Read now
Peter J.K. van Meer, Marlous Kooijman, Vera Brinks, Christine C. Gispen-de Wied, Beatriz Silva-Lima, Ellen H.M. Moors & Huub Schellekens. (2013) Immunogenicity of mAbs in non-human primates during nonclinical safety assessment. mAbs 5:5, pages 810-816.
Read now
Read now
Jonathan Moggs, Pierre Moulin, Francois Pognan, Dominique Brees, Michele Leonard, Steve Busch, Andre Cordier, David J Heard, Michael Kammüller, Michael Merz, Page Bouchard & Salah-Dine Chibout. (2012) Investigative safety science as a competitive advantage for Pharma. Expert Opinion on Drug Metabolism & Toxicology 8:9, pages 1071-1082.
Read now
Read now
Margaret Clotworthy. (2012) The application of human tissue for drug discovery and development. Expert Opinion on Drug Discovery 7:7, pages 543-547.
Read now
Read now
Alain Beck & Thierry Wurch. (2011) 6th Annual European Antibody Congress 2010. mAbs 3:2, pages 111-132.
Read now
Read now
Daniel R. Getts, Meghann T. Getts, Derrick P. McCarthy, Emily ML Chastain & Stephen D. Miller. (2010) Have we overestimated the benefit of human(ized) antibodies?. mAbs 2:6, pages 682-694.
Read now
Read now
Articles from other publishers (166)
F. Donelson Smith, Robert H. Pierce, Thomas Thisted & Edward H. van der Horst. (2023) Conditionally Active, pH-Sensitive Immunoregulatory Antibodies Targeting VISTA and CTLA-4 Lead an Emerging Class of Cancer Therapeutics. Antibodies 12:3, pages 55.
Crossref
Crossref
Fabiana Furci, Nicoletta Luxi, Gianenrico Senna & Gianluca Trifirò. (2023) Anaphylaxis due to antiallergic and antiasthmatic biologics. Current Opinion in Allergy & Clinical Immunology.
Crossref
Crossref
Chaitrali Shevkar & Abhijeet S. Kate. 2023. Natural Immunomodulators: Promising Therapy for Disease Management. Natural Immunomodulators: Promising Therapy for Disease Management
216
242
.
Ibrahim A. Darwish, Nourah Z. Alzoman & Nehal N. Khalil. (2023) A Novel Highly Sensitive Chemiluminescence Enzyme Immunoassay with Signal Enhancement Using Horseradish Peroxidase-Luminol-Hydrogen Peroxide Reaction for the Quantitation of Monoclonal Antibodies Used for Cancer Immunotherapy. Chemosensors 11:4, pages 245.
Crossref
Crossref
Michael Chary, Alexander F. Barbuto, Sudeh Izadmehr, Marc Tarsillo, Eduardo Fleischer & Michele M. Burns. (2023) COVID-19 Therapeutics: Use, Mechanism of Action, and Toxicity (Vaccines, Monoclonal Antibodies, and Immunotherapeutics). Journal of Medical Toxicology 19:2, pages 205-218.
Crossref
Crossref
Julie Kanter, R. Clark Brown, Cynthia Norris, Santosh M. Nair, Abdullah Kutlar, Deepa Manwani, Nirmish Shah, Chiaki Tanaka, Shankaranand Bodla, Gessami Sanchez-Olle, Urs Albers & Darla Liles. (2023) Pharmacokinetics, pharmacodynamics, safety, and efficacy of crizanlizumab in patients with sickle cell disease. Blood Advances 7:6, pages 943-952.
Crossref
Crossref
Hsiao-Tzu Chien, Helen Prior, Laura Andrews, Leon van Aerts, Annick Cauvin, David O. Clarke, Kaushik Datta, Maggie Dempster, Noel Dybdal, Wendy Freebern, Lolke de Haan, Danuta Herzyk, Adam Hey, Thomas Kissner, Sven Kronenberg, Michael W. Leach, Donna Lee, Katrin Schutte, Fiona Sewell, Kevin Trouba, Peter Ulrich, Lucinda Weir & Peter van Meer. (2023) Re-evaluating the need for chronic toxicity studies with therapeutic monoclonal antibodies, using a weight of evidence approach. Regulatory Toxicology and Pharmacology 138, pages 105329.
Crossref
Crossref
Adriana Stucchi, Federica Maspes, Ely Montee-Rodrigues & Georgia Fousteri. (2023) Engineered Treg cells: The heir to the throne of immunotherapy. Journal of Autoimmunity, pages 102986.
Crossref
Crossref
Bruce L. Zuraw, Marcus Maurer, Daniel J. Sexton & Marco Cicardi. (2023) Therapeutic monoclonal antibodies with a focus on hereditary angioedema. Allergology International 72:1, pages 54-62.
Crossref
Crossref
Daniel E. Speiser, Aadil El-Turabi & Martin F. Bachmann. 2023. Plotkin's Vaccines. Plotkin's Vaccines
736
746.e4
.
Michael W. Leach & Katherine Hammerman. 2023. Haschek and Rousseaux's Handbook of Toxicologic Pathology, Volume 2 : Safety Assessment Environmental Toxicologic Pathology. Haschek and Rousseaux's Handbook of Toxicologic Pathology, Volume 2 : Safety Assessment Environmental Toxicologic Pathology
175
230
.
James Fikes, Christopher Hurst & Eric Tien. 2023. Haschek and Rousseaux's Handbook of Toxicologic Pathology, Volume 2 : Safety Assessment Environmental Toxicologic Pathology. Haschek and Rousseaux's Handbook of Toxicologic Pathology, Volume 2 : Safety Assessment Environmental Toxicologic Pathology
49
64
.
Ronnie Chamanza, Stuart W. Naylor & Jennifer A. Chilton. 2023. Spontaneous Pathology of the Laboratory Non-Human Primate. Spontaneous Pathology of the Laboratory Non-Human Primate
359
405
.
Julia Balaguer, Laura García Hidalgo, Raquel Hladun, Catalina Márquez Vega & Vanesa Pérez Alonso. (2022) Recent Evidence-Based Clinical Guide for the Use of Dinutuximab Beta in Pediatric Patients with Neuroblastoma. Targeted Oncology 18:1, pages 77-93.
Crossref
Crossref
Warren D. Harvey. 2022. Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays. Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays
1
31
.
Xiangjun Fu, Jie Xu, Chengyu Ni, Degang Yu, Haibo Wang, Pan Wang, Man Luo & Jie Yu. (2022) Effects of subchronic exposure of nonylphenol on the expression of immune-related factors and estrogen receptors in the spleen of rats. Environmental Sciences Europe 34:1.
Crossref
Crossref
Deepika Saini, Kumud Madan & Shilpi Chauhan. (2022) Screening of Phytoconstituents from Traditional Plants against SARSCoV-
2 using Molecular Docking Approach. Letters in Drug Design & Discovery 19:11, pages 1022-1038.
Crossref
Crossref
Chenglong Liu, Mengxuan Yang, Daizhou Zhang, Ming Chen & Di Zhu. (2022) Clinical cancer immunotherapy: Current progress and prospects. Frontiers in Immunology 13.
Crossref
Crossref
Tatiana Flisikowska, Jerome Egli, Krzysztof Flisikowski, Marlene Stumbaum, Erich Küng, Martin Ebeling, Roland Schmucki, Guy Georges, Thomas Singer, Mayuko Kurome, Barbara Kessler, Valeri Zakhartchenko, Eckhard Wolf, Felix Weber, Angelika Schnieke & Antonio Iglesias. (2022) A humanized minipig model for the toxicological testing of therapeutic recombinant antibodies. Nature Biomedical Engineering 6:11, pages 1248-1256.
Crossref
Crossref
Ying Li, Wei Jiang & Elizabeth D. Mellins. (2022) TCR-like antibodies targeting autoantigen-mhc complexes: a mini-review. Frontiers in Immunology 13.
Crossref
Crossref
Rowan Ives & Kyobin Hwang. (2022) The Diverse Roles of Monoclonal Antibodies in Cancer Immunotherapy and Their Relative Effectiveness: A Literature Review. Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal 6:5, pages 1-10.
Crossref
Crossref
Vibha Jawa, Jad Maamary, Michael Swanson, Shuli Zhang & Diana Montgomery. (2022) Implementing a Clinical Immunogenicity Strategy using Preclinical Risk Assessment Outputs. Journal of Pharmaceutical Sciences 111:4, pages 960-969.
Crossref
Crossref
Subhabrata Majumder, Deep S. Bhattacharya, Alex Langford & Arun Alphonse Ignatius. (2022) Utility of High Resolution 2D NMR Fingerprinting in Assessing Viscosity of Therapeutic Monoclonal Antibodies. Pharmaceutical Research 39:3, pages 529-539.
Crossref
Crossref
Nelli Morgulchik, Foteini Athanasopoulou, Edmund Chu, Yoriko Lam & Nazila Kamaly. (2021) Potential therapeutic approaches for targeted inhibition of inflammatory cytokines following COVID-19 infection-induced cytokine storm. Interface Focus 12:1.
Crossref
Crossref
Peisen Zhang, Yingying Li, Wen Tang, Jie Zhao, Lihong Jing & Kevin J. McHugh. (2022) Theranostic nanoparticles with disease-specific administration strategies. Nano Today 42, pages 101335.
Crossref
Crossref
Beate Bittner & Johannes Schmidt. 2022. Formulation and Device Lifecycle Management of Biotherapeutics. Formulation and Device Lifecycle Management of Biotherapeutics
47
83
.
Giuseppe Barone, Ailish Barry, Francisco Bautista, Bénédicte Brichard, Anne-Sophie Defachelles, Fiona Herd, Carla Manzitti, Dirk Reinhardt, Pedro M. Rubio, Aleksandra Wieczorek & Max M. van Noesel. (2021) Managing Adverse Events Associated with Dinutuximab Beta Treatment in Patients with High-Risk Neuroblastoma: Practical Guidance. Pediatric Drugs 23:6, pages 537-548.
Crossref
Crossref
Patricia Gogesch, Simone Dudek, Ger van Zandbergen, Zoe Waibler & Martina Anzaghe. (2021) The Role of Fc Receptors on the Effectiveness of Therapeutic Monoclonal Antibodies. International Journal of Molecular Sciences 22:16, pages 8947.
Crossref
Crossref
Sol Ferrero, Maria D. Flores, Connor Short, Cecilia A. Vazquez, Lars E. Clark, James Ziegenbein, Samantha Zink, Daniel Fuentes, Cristian Payes, María V. Batto, Michael Collazo, Cybele C. García, Jonathan Abraham, Sandra M. Cordo, Jose A. Rodriguez & Gustavo Helguera. (2021) Antibody-Based Inhibition of Pathogenic New World Hemorrhagic Fever Mammarenaviruses by Steric Occlusion of the Human Transferrin Receptor 1 Apical Domain. Journal of Virology 95:17.
Crossref
Crossref
Wenpan Li, Nicholas Little, Jonghan Park, Cole Alexander Foster, Jiawei Chen & Jianqin Lu. (2021) Tumor-Associated Fibroblast-Targeting Nanoparticles for Enhancing Solid Tumor Therapy: Progress and Challenges. Molecular Pharmaceutics 18:8, pages 2889-2905.
Crossref
Crossref
Dante Descalzi‐Montoya, Rachel A. Montel, Keith Smith, Eugenia Dziopa, Andrieh Darwich, Zheng Yang, Constantine Bitsaktsis, Robert Korngold & David Sabatino. (2020) Synthetic Antibody Mimics Based on Cancer‐Targeting Immunostimulatory Peptides. ChemBioChem 22:9, pages 1589-1596.
Crossref
Crossref
Thierry D. Flandre, Alessandro Piaia & Maurice G. Cary. (2020) Biologic Immunomodulatory Drugs and Infection in the Respiratory Tract of Nonhuman Primates. Toxicologic Pathology 49:2, pages 397-407.
Crossref
Crossref
Deepak Kukkar, Preeti Kukkar, Vanish Kumar, Jongki Hong, Ki-Hyun Kim & Akash Deep. (2021) Recent advances in nanoscale materials for antibody-based cancer theranostics. Biosensors and Bioelectronics 173, pages 112787.
Crossref
Crossref
Daehyun Kim, Seung Soo Lee, Hyungwon Moon, So Yeon Park & Hak Jong Lee. (2020) PD-L1 Targeting Immune-Microbubble Complex Enhances Therapeutic Index in Murine Colon Cancer Models. Pharmaceuticals 14:1, pages 6.
Crossref
Crossref
Jessica C. Graham, Jedd Hillegass & Gene Schulze. (2020) Considerations for setting occupational exposure limits for novel pharmaceutical modalities. Regulatory Toxicology and Pharmacology 118, pages 104813.
Crossref
Crossref
Fleury Augustin Nsole Biteghe, Neelakshi Mungra, Nyangone Ekome Toung Chalomie, Jean De La Croix Ndong, Jean Engohang-Ndong, Guillaume Vignaux, Eden Padayachee, Krupa Naran & Stefan Barth. (2020) Advances in epidermal growth factor receptor specific immunotherapy: lessons to be learned from armed antibodies. Oncotarget 11:38, pages 3531-3557.
Crossref
Crossref
Fleury Augustin Nsole Biteghe, Nyangone Ekome Toung Chalomie, Neelakshi Mungra, Guillaume Vignaux, Nan Gao, Aurelia Vergeade, Ambrose Okem, Krupa Naran, Jean De La Croix Ndong & Stefan Barth. (2020) Antibody-Based Immunotherapy: Alternative Approaches for the Treatment of Metastatic Melanoma. Biomedicines 8:9, pages 327.
Crossref
Crossref
Bwalya A. Witika, Pedzisai A. Makoni, Scott K. Matafwali, Billy Chabalenge, Chiluba Mwila, Aubrey C. Kalungia, Christian I. Nkanga, Alain M. Bapolisi & Roderick B. Walker. (2020) Biocompatibility of Biomaterials for Nanoencapsulation: Current Approaches. Nanomaterials 10:9, pages 1649.
Crossref
Crossref
Brendan L. Hagerty, Guillaume J. Pegna, Jian Xu, Chin-Hsien Tai & Christine Alewine. (2020) Mesothelin-Targeted Recombinant Immunotoxins for Solid Tumors. Biomolecules 10:7, pages 973.
Crossref
Crossref
Joanne Marie M. Del Rosario, Matthew Smith, Kam Zaki, Paul Risley, Nigel Temperton, Othmar G. Engelhardt, Mary Collins, Yasuhiro Takeuchi & Simon E. Hufton. (2020) Protection From Influenza by Intramuscular Gene Vector Delivery of a Broadly Neutralizing Nanobody Does Not Depend on Antibody Dependent Cellular Cytotoxicity. Frontiers in Immunology 11.
Crossref
Crossref
Shota Yoshida, Hironori Nakagami, Hiroki Hayashi, Yuka Ikeda, Jiao Sun, Akiko Tenma, Hideki Tomioka, Tomohiro Kawano, Munehisa Shimamura, Ryuichi Morishita & Hiromi Rakugi. (2020) The CD153 vaccine is a senotherapeutic option for preventing the accumulation of senescent T cells in mice. Nature Communications 11:1.
Crossref
Crossref
Zahra Aryan, Mahsa Keshavarz-Fathi, Håkan Mellstedt & Nima Rezaei. 2020. Cancer Immunology. Cancer Immunology
1
48
.
Jinze Li, Mayur S. Mitra & Gautham K. Rao. 2020. Immuno-Oncology. Immuno-Oncology
199
238
.
Mark T. J. van Bussel, Jos H. Beijnen & Dieta Brandsma. (2019) Intracranial antitumor responses of nivolumab and ipilimumab: a pharmacodynamic and pharmacokinetic perspective, a scoping systematic review. BMC Cancer 19:1.
Crossref
Crossref
Mingye Feng, Wen Jiang, Betty Y. S. Kim, Cheng Cheng Zhang, Yang-Xin Fu & Irving L. Weissman. (2019) Phagocytosis checkpoints as new targets for cancer immunotherapy. Nature Reviews Cancer 19:10, pages 568-586.
Crossref
Crossref
Jiqiao Yang, Xiujing He, Qing Lv, Jing Jing & Hubing Shi. (2019) Management of Adverse Events in Cancer Patients Treated With PD-1/PD-L1 Blockade: Focus on Asian Populations. Frontiers in Pharmacology 10.
Crossref
Crossref
Robert Dingman & Sathy V. Balu-Iyer. (2019) Immunogenicity of Protein Pharmaceuticals. Journal of Pharmaceutical Sciences 108:5, pages 1637-1654.
Crossref
Crossref
Jiani Xiong, Caiyun Zhang, Shuifa Wu, Xiaofan Gu, Yumei Cai, Chunseng Xu, Zhou Chen, Jiancheng Sun, Xiangxin Wu, Xiuhua You, Zhihong Huang & Jieming Xie. (2019) Recombinant cucurmosin-based immunotoxin targeting HER-2 with potent in vitro anti-cancer cytotoxicity. Biochemical and Biophysical Research Communications 513:1, pages 15-21.
Crossref
Crossref
Honghui Zhou & Diane R. MouldHaiqing Wang, Zheng Yang & Rong Shi. 2019. Quantitative Pharmacology and Individualized Therapy Strategies in Development of Therapeutic Proteins for Immune‐Mediated Inflammatory Diseases. Quantitative Pharmacology and Individualized Therapy Strategies in Development of Therapeutic Proteins for Immune‐Mediated Inflammatory Diseases
65
91
.
Mengrui Liu, Wantong Song & Leaf Huang. (2019) Drug delivery systems targeting tumor-associated fibroblasts for cancer immunotherapy. Cancer Letters 448, pages 31-39.
Crossref
Crossref
Hannah Morgan, Su-Yi Tseng, Yann Gallais, Margret Leineweber, Pascale Buchmann, Sabrina Riccardi, Myriam Nabhan, Jeannette Lo, Zaahira Gani, Natacha Szely, Cornelia S. Zhu, Ming Yang, Andrea Kiessling, Hans-Werner Vohr, Marc Pallardy, Fred Aswad & Isabelle Turbica. (2019) Evaluation of in vitro Assays to Assess the Modulation of Dendritic Cells Functions by Therapeutic Antibodies and Aggregates. Frontiers in Immunology 10.
Crossref
Crossref
Andrew T. Lucas, Ryan Robinson, Allison N. Schorzman, Joseph A. Piscitelli, Juan F. Razo & William C. Zamboni. (2019) Pharmacologic Considerations in the Disposition of Antibodies and Antibody-Drug Conjugates in Preclinical Models and in Patients. Antibodies 8:1, pages 3.
Crossref
Crossref
Tiene Bauters & Johan Vandenbroucke. (2017) Development of a flowchart for risk assessment and allocation of preparation of monoclonal antibodies. Journal of Oncology Pharmacy Practice 25:1, pages 187-191.
Crossref
Crossref
Haitham AlRabiah, Mohammed A. Hamidaddin & Ibrahim A. Darwish. (2019) Automated flow fluorescent noncompetitive immunoassay for measurement of human plasma levels of monoclonal antibodies used for immunotherapy of cancers with KinExA™ 3200 biosensor. Talanta 192, pages 331-338.
Crossref
Crossref
Karl Erik Hellstrom & Ingegerd Hellstrom. 2019. Cancer Immunotherapy. Cancer Immunotherapy
1
24
.
Cynthia Kassab, Brittany Parker Kerrigan, Hillary Caruso, Sanaalarab Al Enazy & Amy B. Heimberger. 2019. Nervous System Drug Delivery. Nervous System Drug Delivery
297
334
.
Frank R. Brennan, Emma Smith & Sherri Dudal. 2019. Nijkamp and Parnham's Principles of Immunopharmacology. Nijkamp and Parnham's Principles of Immunopharmacology
369
406
.
Tracey L. Papenfuss, Marlon C. Rebelatto & Brad Bolon. 2019. Toxicologic Pathology for Non-Pathologists. Toxicologic Pathology for Non-Pathologists
355
395
.
Ronit Mazor, Emily King & Ira Pastan. (2018) Anti-drug antibodies to LMB-100 are enhanced by mAbs targeting OX40 and CTLA4 but not by mAbs targeting PD1 or PDL-1. Cellular Immunology 334, pages 38-41.
Crossref
Crossref
Jane Harper, Katherine J. Adams, Giovanna Bossi, Debbie E. Wright, Andrea R. Stacey, Nicole Bedke, Ruth Martinez-Hague, Dan Blat, Laure Humbert, Hazel Buchanan, Gabrielle S. Le Provost, Zoe Donnellan, Ricardo J. Carreira, Samantha J. Paston, Luise U. Weigand, Martina Canestraro, Joseph P. Sanderson, Sophie Botta Gordon-Smith, Kate L. Lowe, Karolina A. Rygiel, Alex S. Powlesland, Annelise Vuidepot, Namir J. Hassan, Brian J. Cameron, Bent K. Jakobsen & Joseph Dukes. (2018) An approved in vitro approach to preclinical safety and efficacy evaluation of engineered T cell receptor anti-CD3 bispecific (ImmTAC) molecules. PLOS ONE 13:10, pages e0205491.
Crossref
Crossref
Frank R. Brennan, Laura Andrews, Antonio R. Arulanandam, Jorg Blumel, Jim Fikes, Christine Grimaldi, Janice Lansita, Lise I. Loberg, Tim MacLachlan, Mark Milton, Suezanne Parker, Jay Tibbitts, Jayanthi Wolf & Krishna P. Allamneni. (2018) Current strategies in the non-clinical safety assessment of biologics: New targets, new molecules, new challenges. Regulatory Toxicology and Pharmacology 98, pages 98-107.
Crossref
Crossref
Mohammed A. Hamidaddin, Haitham AlRabiah & Ibrahim A. Darwish. (2018) Development and validation of generic heterogeneous fluoroimmunoassay for bioanalysis of bevacizumab and cetuximab monoclonal antibodies used for cancer immunotherapy. Talanta 188, pages 562-569.
Crossref
Crossref
Ying Wang, Wantong Song, Mengying Hu, Sai An, Ligeng Xu, Jingjing Li, Karina A. Kinghorn, Rihe Liu & Leaf Huang. (2018) Nanoparticle‐mediated HMGA1 Silencing Promotes Lymphocyte Infiltration and Boosts Checkpoint Blockade Immunotherapy for Cancer. Advanced Functional Materials 28:36.
Crossref
Crossref
Sahar Awwad & Ukrit Angkawinitwong. (2018) Overview of Antibody Drug Delivery. Pharmaceutics 10:3, pages 83.
Crossref
Crossref
Gilad Kaplan, Ronit Mazor, Fred Lee, Youjin Jang, Yasmin Leshem & Ira Pastan. (2018)
Improving the
In Vivo
Efficacy of an Anti-Tac (CD25) Immunotoxin by
Pseudomonas
Exotoxin A Domain II Engineering
. Molecular Cancer Therapeutics 17:7, pages 1486-1493.
Crossref
Crossref
Peter Ulrich, Guenter Blaich, Andreas Baumann, Rajni Fagg, Adam Hey, Andrea Kiessling, Sven Kronenberg, Rikke Hvid Lindecrona, Silke Mohl, Wolfgang F. Richter, Jay Tibbitts, Flavio Crameri & Lucinda Weir. (2018) Biotherapeutics in non-clinical development: Strengthening the interface between safety, pharmacokinetics-pharmacodynamics and manufacturing. Regulatory Toxicology and Pharmacology 94, pages 91-100.
Crossref
Crossref
Tamás Fülöp, Tamás Mészáros, Gergely Kozma, János Szebeni & Mihály Józsi. (2018) Infusion Reactions Associated with the Medical Application of Monoclonal Antibodies: The Role of Complement Activation and Possibility of Inhibition by Factor H. Antibodies 7:1, pages 14.
Crossref
Crossref
María Elena Iezzi, Lucía Policastro, Santiago Werbajh, Osvaldo Podhajcer & Gabriela Alicia Canziani. (2018) Single-Domain Antibodies and the Promise of Modular Targeting in Cancer Imaging and Treatment. Frontiers in Immunology 9.
Crossref
Crossref
M T Bhatti & A K S Salama. (2017) Neuro-ophthalmic side effects of molecularly targeted cancer drugs. Eye 32:2, pages 287-301.
Crossref
Crossref
Aadil El-Turabi & Martin F. Bachmann. 2018. Plotkin's Vaccines. Plotkin's Vaccines
689
697.e4
.
M.S. Piche, W.J. Freebern & U. Herbrand. 2018. Comprehensive Toxicology. Comprehensive Toxicology
361
375
.
L.I. Loberg & K.A. Archer. 2018. Comprehensive Toxicology. Comprehensive Toxicology
343
360
.
Bradley J. Scott & Jian Wang. 2018. Biosimilars. Biosimilars
123
144
.
L. Peyton Myers. 2018. Immunotoxicity Testing. Immunotoxicity Testing
15
26
.
Frank R. Brennan & Andrea Kiessling. (2017) In vitro assays supporting the safety assessment of immunomodulatory monoclonal antibodies. Toxicology in Vitro 45, pages 296-308.
Crossref
Crossref
Haleh Saber, Pedro Del Valle, Tiffany K. Ricks & John K. Leighton. (2017) An FDA oncology analysis of CD3 bispecific constructs and first-in-human dose selection. Regulatory Toxicology and Pharmacology 90, pages 144-152.
Crossref
Crossref
Alina Vasilescu, Samia Boulahneche, Fereshteh Chekin, Szilveszter Gáspár, Mohamed Salah Medjram, Abdou Aziz Diagne, Santosh K. Singh, Sreekumar Kurungot, Rabah Boukherroub & Sabine Szunerits. (2017) Porous reduced graphene oxide modified electrodes for the analysis of protein aggregation. Part 1: Lysozyme aggregation at pH 2 and 7.4. Electrochimica Acta 254, pages 375-383.
Crossref
Crossref
Kristina M. Ilieva, Judit Fazekas-Singer, Daniela Y. Achkova, Tihomir S. Dodev, Silvia Mele, Silvia Crescioli, Heather J. Bax, Anthony Cheung, Panagiotis Karagiannis, Isabel Correa, Mariangela Figini, Rebecca Marlow, Debra H. Josephs, Andrew J. Beavil, John Maher, James F. Spicer, Erika Jensen-Jarolim, Andrew N. Tutt & Sophia N. Karagiannis. (2017) Functionally Active Fc Mutant Antibodies Recognizing Cancer Antigens Generated Rapidly at High Yields. Frontiers in Immunology 8.
Crossref
Crossref
Yehudit Grinberg & Itai Benhar. (2017) Addressing the Immunogenicity of the Cargo and of the Targeting Antibodies with a Focus on Deimmunized Bacterial Toxins and on Antibody-Targeted Human Effector Proteins. Biomedicines 5:4, pages 28.
Crossref
Crossref
Nicole A. Belmar, Sarah W. Chan, Melvin I. Fox, Josue A. Samayoa, Marcia M. Stickler, Ninian N. Tran, Yoshiko Akamatsu, Diane Hollenbaugh, Fiona A. Harding & Hamsell M. Alvarez. (2017) Murinization and H Chain Isotype Matching of the Anti-GITR Antibody DTA-1 Reduces Immunogenicity-Mediated Anaphylaxis in C57BL/6 Mice. The Journal of Immunology 198:11, pages 4502-4512.
Crossref
Crossref
Kirsten M. Mease, Amy L. Kimzey & Janice A. Lansita. (2017) Biomarkers for nonclinical infusion reactions in marketed biotherapeutics and considerations for study design. Current Opinion in Toxicology 4, pages 1-15.
Crossref
Crossref
Leticia Herminia Higa, Horacio Emanuel Jerez, Marcelo Alexandre de Farias, Rodrigo Villares Portugal, Eder Lilia Romero & Maria Jose Morilla. (2017) Ultra-small solid archaeolipid nanoparticles for active targeting to macrophages of the inflamed mucosa. Nanomedicine 12:10, pages 1165-1175.
Crossref
Crossref
Alyse D. Portnoff, Cuihua Gao, M. Jack Borrok, Xizhe Gao, Changshou Gao & G. Jonah Rainey. (2017) An antidote approach to reduce risk and broaden utility of antibody-based therapeutics. Journal of Biological Chemistry 292:20, pages 8498-8506.
Crossref
Crossref
Benjamin P. Davis & Zuhair K. Ballas. (2017) Biologic response modifiers: Indications, implications, and insights. Journal of Allergy and Clinical Immunology 139:5, pages 1445-1456.
Crossref
Crossref
Yann Gallais, Natacha Szely, François‐Xavier Legrand, Arnaud Leroy, Marc Pallardy & Isabelle Turbica. (2016) Effect of growth hormone and IgG aggregates on dendritic cells activation and T‐cells polarization. Immunology & Cell Biology 95:3, pages 306-315.
Crossref
Crossref
Priyasma Bhoumik, Alberto Del Rio-Espinola, Florian Hahne, Jonathan Moggs & Olivier Grenet. (2016) Translational Safety Genetics. Toxicologic Pathology 45:1, pages 119-126.
Crossref
Crossref
K.B. Meyer-Tamaki. 2017. A Comprehensive Guide to Toxicology in Nonclinical Drug Development. A Comprehensive Guide to Toxicology in Nonclinical Drug Development
617
645
.
Adam Seidelin Hey. 2017. Recombinant Antibodies for Infectious Diseases. Recombinant Antibodies for Infectious Diseases
265
294
.
Molly H. Boyle. 2017. Immunopathology in Toxicology and Drug Development. Immunopathology in Toxicology and Drug Development
455
477
.
Josely F. Figueiredo, Kirstin F. Barnhart & Niraj Tripathi. 2017. Immunopathology in Toxicology and Drug Development. Immunopathology in Toxicology and Drug Development
457
488
.
George A. Parker & Tracey L. Papenfuss. 2017. Immunopathology in Toxicology and Drug Development. Immunopathology in Toxicology and Drug Development
1
93
.
Kasper Lamberth, Karin Nana Weldingh, Silke Ehrenforth, Mette Ribel Chéhadé & Henrik Østergaard. 2017. Protein Therapeutics. Protein Therapeutics
123
160
.
Shomron Ben-Horin, Niels Vande Casteele, Stefan Schreiber & Peter Laszlo Lakatos. (2016) Biosimilars in Inflammatory Bowel Disease: Facts and Fears of Extrapolation. Clinical Gastroenterology and Hepatology 14:12, pages 1685-1696.
Crossref
Crossref
Thomas Hünig. (2016) The rise and fall of the CD28 superagonist TGN1412 and its return as TAB08: a personal account. The FEBS Journal 283:18, pages 3325-3334.
Crossref
Crossref
Paul W. Snyder, Nancy E. Everds, W. A. Craven, Jonathan Werner, Sarah H. Tannehill-Gregg & Roberto E. Guzman. (2016)
Maturity-related Variability of the Thymus in Cynomolgus Monkeys (
Macaca fascicularis
)
. Toxicologic Pathology 44:6, pages 874-891.
Crossref
Crossref
Diane R. Mould & Bernd Meibohm. (2016) Drug Development of Therapeutic Monoclonal Antibodies. BioDrugs 30:4, pages 275-293.
Crossref
Crossref
E. S. Zhavbert, E. I. Surkova, N. N. Yakovleva, Yu. L. Dugina, O. I. Epshtein, L. I. Bugaeva, S. A. Lebedeva & V. I. Petrov. (2016) Preclinical Toxicological Study of Release-Active Preparations for Prediction of Their Pharmacological Activity and Side Effects. Bulletin of Experimental Biology and Medicine 161:2, pages 252-256.
Crossref
Crossref
Xu Zhu & Ellen Evans. 2016. Drug Discovery Toxicology. Drug Discovery Toxicology
193
200
.
Ronit Mazor, Masanori Onda & Ira Pastan. (2016) Immunogenicity of therapeutic recombinant immunotoxins. Immunological Reviews 270:1, pages 152-164.
Crossref
Crossref
N Landolina & F Levi-Schaffer. (2016) Monoclonal antibodies: the new magic bullets for allergy: IUPHAR Review 17. British Journal of Pharmacology 173:5, pages 793-803.
Crossref
Crossref
N. D. Brunn, S. Mauze, D. Gu, D. Wiswell, R. Ueda, D. Hodges, A. M. Beebe, S. Zhang & E. Escandon. (2015) The Role of Anti-Drug Antibodies in the Pharmacokinetics, Disposition, Target Engagement, and Efficacy of a GITR Agonist Monoclonal Antibody in Mice. Journal of Pharmacology and Experimental Therapeutics 356:3, pages 574-586.
Crossref
Crossref
Yoshika IwataAsako HaradaToshiko HaraChiyomi KuboTomoaki InoueMitsuyasu TaboCorinne Ploix, Tobias Manigold, Heather Hinton & Masayuki Mishima. (2016) Is an <i>in vitro</i> whole blood cytokine assay useful to detect the potential risk of severe infusion reaction of monoclonal antibody pharmaceuticals?. The Journal of Toxicological Sciences 41:4, pages 523-531.
Crossref
Crossref
Niloufar Ataie, Jingyi Xiang, Neal Cheng, Elliott J. Brea, Wenjie Lu, David A. Scheinberg, Cheng Liu & Ho Leung Ng. (2016) Structure of a TCR-Mimic Antibody with Target Predicts Pharmacogenetics. Journal of Molecular Biology 428:1, pages 194-205.
Crossref
Crossref
Eva Cecrdlova, Katerina Petrickova, Libor Kolesar, Miroslav Petricek, Alena Sekerkova, Veronika Svachova & Ilja Striz. (2016) Manumycin A downregulates release of proinflammatory cytokines from TNF alpha stimulated human monocytes. Immunology Letters 169, pages 8-14.
Crossref
Crossref
Peng Zou, Sau Lee, Min Li, Lawrence Yu & Duxin Sun. 2016. Pharmacokinetics in Drug Development. Pharmacokinetics in Drug Development
39
58
.
Jesús Zurdo, Andreas Arnell, Olga Obrezanova, Noel Smith, Thomas Gallagher, Ramón de la Cuesta & Ben Locwin. 2015. Developability of Biotherapeutics. Developability of Biotherapeutics
221
290
.
Jing Lu, Linda Lee-Gabel, Michelle C Nadeau, Thomas M Ferencz & Scott A Soefje. (2014) Clinical evaluation of compounds targeting PD-1/PD-L1 pathway for cancer immunotherapy. Journal of Oncology Pharmacy Practice 21:6, pages 451-467.
Crossref
Crossref
Anna M. Davies & Brian J. Sutton. (2015) Human IgG4: a structural perspective. Immunological Reviews 268:1, pages 139-159.
Crossref
Crossref
Lei Miao, Yuhua Wang, C. Michael Lin, Yang Xiong, Naihan Chen, Lu Zhang, William Y. Kim & Leaf Huang. (2015) Nanoparticle modulation of the tumor microenvironment enhances therapeutic efficacy of cisplatin. Journal of Controlled Release 217, pages 27-41.
Crossref
Crossref
N. Yamazaki, Y. Kiyohara, H. Uhara, S. Fukushima, H. Uchi, N. Shibagaki, A. Tsutsumida, S. Yoshikawa, R. Okuyama, Y. Ito & T. Tokudome. (2015) Phase II study of ipilimumab monotherapy in Japanese patients with advanced melanoma. Cancer Chemotherapy and Pharmacology 76:5, pages 997-1004.
Crossref
Crossref
Anja Derer, Lisa Deloch, Yvonne Rubner, Rainer Fietkau, Benjamin Frey & Udo S. Gaipl. (2015) Radio-Immunotherapy-Induced Immunogenic Cancer Cells as Basis for Induction of Systemic Anti-Tumor Immune Responses – Pre-Clinical Evidence and Ongoing Clinical Applications. Frontiers in Immunology 6.
Crossref
Crossref
Stephen Silberstein, Robert Lenz & Cen Xu. (2015) Therapeutic Monoclonal Antibodies: What Headache Specialists Need to Know. Headache: The Journal of Head and Face Pain 55:8, pages 1171-1182.
Crossref
Crossref
Jennifer L. MacIntyre, Avanish K. Varshney, Xiaobo Wang, Scott Gatto, Clarence Friedman, Yan Liu, Kelvin Kerns, Oleg Kovalenko, Karissa Adkins, Richard Zollner, Bettina C. Fries & Fergus R. Byrne. (2015) Optimization of experimental conditions for functional in vitro characterization of humanized antibodies specific for staphylococcal enterotoxin B. International Immunopharmacology 28:1, pages 354-358.
Crossref
Crossref
Tracey E. Sciuto, Anne Merley, Chi-Iou Lin, Douglas Richardson, Yu Liu, Dan Li, Ann M. Dvorak, Harold F. Dvorak & Shou-Ching S. Jaminet. (2015) Intracellular distribution of TM4SF1 and internalization of TM4SF1-antibody complex in vascular endothelial cells. Biochemical and Biophysical Research Communications 465:3, pages 338-343.
Crossref
Crossref
Hidehito Horinouchi, Noboru Yamamoto, Yutaka Fujiwara, Ikuo Sekine, Hiroshi Nokihara, Kaoru Kubota, Shintaro Kanda, Shigehiro Yagishita, Hiroshi Wakui, Satoru Kitazono, Hidenori Mizugaki, Takuto Tokudome & Tomohide Tamura. (2015) Phase I study of ipilimumab in phased combination with paclitaxel and carboplatin in Japanese patients with non-small-cell lung cancer. Investigational New Drugs 33:4, pages 881-889.
Crossref
Crossref
Sandhya Jinesh. (2015) Pharmaceutical aspects of anti-inflammatory TNF-blocking drugs. Inflammopharmacology 23:2-3, pages 71-77.
Crossref
Crossref
H Tanaka, G-X Yang, T Tomiyama, K Tsuneyama, W Zhang, P S C Leung, R L Coppel, T Joh, S G Nadler, A A Ansari, C Bowlus & M E Gershwin. (2015) Immunological potential of cytotoxic T lymphocyte antigen 4 immunoglobulin in murine autoimmune cholangitis. Clinical and Experimental Immunology 180:3, pages 371-382.
Crossref
Crossref
Bradley J. Scott, Agnes V. Klein & Jian Wang. (2015) Biosimilar monoclonal antibodies: A Canadian regulatory perspective on the assessment of clinically relevant differences and indication extrapolation. The Journal of Clinical Pharmacology 55:S3, pages S123-S132.
Crossref
Crossref
Piotr Pierog, Murli Krishna, Aaron Yamniuk, Anil Chauhan & Binodh DeSilva. (2015) Detection of drug specific circulating immune complexes from in vivo cynomolgus monkey serum samples. Journal of Immunological Methods 416, pages 124-136.
Crossref
Crossref
Jacintha M. Shenton, Kristin L. Henson & Marlon C. Rebelatto. 2015. The Nonhuman Primate in Nonclinical Drug Development and Safety Assessment. The Nonhuman Primate in Nonclinical Drug Development and Safety Assessment
215
234
.
Zahra Aryan, Håkan Mellstedt & Nima Rezaei. 2015. Cancer Immunology. Cancer Immunology
1
39
.
Stephen Senn. 2014. Statistical Methods for Evaluating Safety in Medical Product Development. Statistical Methods for Evaluating Safety in Medical Product Development
84
98
.
Rafael A. Ponce. 2014. Molecular Immunotoxicology. Molecular Immunotoxicology
159
188
.
Tsuguto Toda & Kazuichi Nakamura. 2014. Molecular Immunotoxicology. Molecular Immunotoxicology
145
158
.
Ellen W. Evans. (2013) Regulatory Forum Commentary*. Toxicologic Pathology 42:7, pages 1053-1057.
Crossref
Crossref
Fiona Sewell, Kathryn Chapman, Paul Baldrick, David Brewster, Alan Broadmeadow, Paul Brown, Leigh Ann Burns-Naas, Janet Clarke, Alex Constan, Jessica Couch, Oliver Czupalla, Andy Danks, Joseph DeGeorge, Lolke de Haan, Klaudia Hettinger, Marilyn Hill, Matthias Festag, Abby Jacobs, David Jacobson-Kram, Stephan Kopytek, Helga Lorenz, Sophia Gry Moesgaard, Emma Moore, Markku Pasanen, Rick Perry, Ian Ragan, Sally Robinson, Petra M. Schmitt, Brian Short, Beatriz Silva Lima, Diane Smith, Sue Sparrow, Yvette van Bekkum & David Jones. (2014) Recommendations from a global cross-company data sharing initiative on the incorporation of recovery phase animals in safety assessment studies to support first-in-human clinical trials. Regulatory Toxicology and Pharmacology 70:1, pages 413-429.
Crossref
Crossref
Frank R. Brennan. 2014. Handbook of Therapeutic Antibodies. Handbook of Therapeutic Antibodies
927
968
.
Alessandra Vultaggio & Mariana C. Castells. (2014) Hypersensitivity Reactions to Biologic Agents. Immunology and Allergy Clinics of North America 34:3, pages 615-632.
Crossref
Crossref
Jennifer L. Rojko, Mark G. Evans, Shari A. Price, Bora Han, Gary Waine, Mark DeWitte, Jill Haynes, Bruce Freimark, Pauline Martin, James T. Raymond, Winston Evering, Marlon C. Rebelatto, Emanuel Schenck & Christopher Horvath. (2014) Formation, Clearance, Deposition, Pathogenicity, and Identification of Biopharmaceutical-related Immune Complexes. Toxicologic Pathology 42:4, pages 725-764.
Crossref
Crossref
Frank R. Brennan, Annick Cauvin, Jay Tibbitts & Alison Wolfreys. (2014) Optimized Nonclinical Safety Assessment Strategies Supporting Clinical Development of Therapeutic Monoclonal Antibodies Targeting Inflammatory Diseases. Drug Development Research, pages n/a-n/a.
Crossref
Crossref
Minoru Tada, Akiko Ishii-Watabe, Takuo Suzuki & Nana Kawasaki. (2014) Development of a Cell-Based Assay Measuring the Activation of FcγRIIa for the Characterization of Therapeutic Monoclonal Antibodies. PLoS ONE 9:4, pages e95787.
Crossref
Crossref
David R. Jones & James W. McBlane. 2014. Mann's Pharmacovigilance. Mann's Pharmacovigilance
95
108
.
S. Gaylen Bradley. 2005. Encyclopedia of Immunotoxicology. Encyclopedia of Immunotoxicology
1
5
.
Rick Perry, Georgia Farris, Jean-Guy Bienvenu, Charles DeanJrJr, George Foley, Chuck Mahrt & Brian Short. (2013) Society of Toxicologic Pathology Position Paper on Best Practices on Recovery Studies. Toxicologic Pathology 41:8, pages 1159-1169.
Crossref
Crossref
Marina A. Dobrovolskaia & Scott E. McNeil. (2013) Understanding the correlation between in vitro and in vivo immunotoxicity tests for nanomedicines. Journal of Controlled Release 172:2, pages 456-466.
Crossref
Crossref
Liangbiao George Hu & David W. Clarke. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia
1
26
.
H Tanaka, G-X Yang, N Iwakoshi, S J Knechtle, K Kawata, K Tsuneyama, P Leung, R L Coppel, A A Ansari, T Joh, C Bowlus & M E Gershwin. (2013) Anti-CD40 ligand monoclonal antibody delays the progression of murine autoimmune cholangitis. Clinical and Experimental Immunology 174:3, pages 364-371.
Crossref
Crossref
Kerry Routenberg Love, Sangram Bagh, Jonghoon Choi & J. Christopher Love. (2013) Microtools for single-cell analysis in biopharmaceutical development and manufacturing. Trends in Biotechnology 31:5, pages 280-286.
Crossref
Crossref
Shui-Long Wang, Scott Hauenstein, Linda Ohrmund, Reshma Shringarpure, Jared Salbato, Rukmini Reddy, Kevin McCowen, Shawn Shah, Steven Lockton, Emil Chuang & Sharat Singh. (2013) Monitoring of adalimumab and antibodies-to-adalimumab levels in patient serum by the homogeneous mobility shift assay. Journal of Pharmaceutical and Biomedical Analysis 78-79, pages 39-44.
Crossref
Crossref
Leigh Ann Burns‐Naas & Marc J. Pallardy. 2013. Nonclinical Safety Assessment. Nonclinical Safety Assessment
313
346
.
Jesús Zurdo. (2013) Developability assessment as an early de-risking tool for biopharmaceutical development. Pharmaceutical Bioprocessing 1:1, pages 29-50.
Crossref
Crossref
Jean G. Sathish, Swaminathan Sethu, Marie-Christine Bielsky, Lolke de Haan, Neil S. French, Karthik Govindappa, James Green, Christopher E. M. Griffiths, Stephen Holgate, David Jones, Ian Kimber, Jonathan Moggs, Dean J. Naisbitt, Munir Pirmohamed, Gabriele Reichmann, Jennifer Sims, Meena Subramanyam, Marque D. Todd, Jan Willem Van Der Laan, Richard J. Weaver & B. Kevin Park. (2013) Challenges and approaches for the development of safer immunomodulatory biologics. Nature Reviews Drug Discovery 12:4, pages 306-324.
Crossref
Crossref
Irina L. Tutykhina, Elena S. Sedova, Irina Y. Gribova, Tatiana I. Ivanova, Lev A. Vasilev, Marina V. Rutovskaya, Andrei A. Lysenko, Maxim M. Shmarov, Denis Y. Logunov, Boris S. Naroditsky, Sergei V. Tillib & Alexander L. Gintsburg. (2013) Passive immunization with a recombinant adenovirus expressing an HA (H5)-specific single-domain antibody protects mice from lethal influenza infection. Antiviral Research 97:3, pages 318-328.
Crossref
Crossref
Jacky Woo, Michel PM Vierboom, Hakju Kwon, Debra Chao, Shiming Ye, Jianmin Li, Karen Lin, Irene Tang, Nicole A Belmar, Taymar Hartman, Elia Breedveld, Vladimir Vexler, Bert A ?t Hart, Debbie A Law & Gary C Starling. (2013) PDL241, a novel humanized monoclonal antibody, reveals CD319 as a therapeutic target for rheumatoid arthritis. Arthritis Research & Therapy 15:6, pages R207.
Crossref
Crossref
C. Frieke Kuper, Christine Ruehl-Fehlert, Susan A. Elmore & George A. Parker. 2013. Haschek and Rousseaux's Handbook of Toxicologic Pathology. Haschek and Rousseaux's Handbook of Toxicologic Pathology
1795
1862
.
Wendy Halpern & David Hutto. 2013. Haschek and Rousseaux's Handbook of Toxicologic Pathology. Haschek and Rousseaux's Handbook of Toxicologic Pathology
751
782
.
Joseph R. Arron, Heleen Scheerens & John G. Matthews. 2013. Immunopharmacology. Immunopharmacology
1
49
.
Padma Kumar Narayanan, Rafael Ponce & Beth Hinkle. 2013. Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics. Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics
65
95
.
Richard A. Westhouse & Bruce D. Car. 2013. Cancer Immunotherapy. Cancer Immunotherapy
187
206
.
Kathleen B. Meyer-Tamaki. 2013. A Comprehensive Guide to Toxicology in Preclinical Drug Development. A Comprehensive Guide to Toxicology in Preclinical Drug Development
489
516
.
Babette Wolf, Hannah Morgan, Jennifer Krieg, Zaahira Gani, Adriana Milicov, Max Warncke, Frank Brennan, Stewart Jones, Jennifer Sims & Andrea Kiessling. (2012) A whole blood in vitro cytokine release assay with aqueous monoclonal antibody presentation for the prediction of therapeutic protein induced cytokine release syndrome in humans. Cytokine 60:3, pages 828-837.
Crossref
Crossref
Jennifer C. Rea, Yun Lou, Joel Cuzzi, Yuhua Hu, Isabella de Jong, Yajun Jennifer Wang & Dell Farnan. (2012) Development of capillary size exclusion chromatography for the analysis of monoclonal antibody fragments extracted from human vitreous humor. Journal of Chromatography A 1270, pages 111-117.
Crossref
Crossref
Shui-Long Wang, Linda Ohrmund, Scott Hauenstein, Jared Salbato, Rukmini Reddy, Patrick Monk, Steven Lockton, Nicholas Ling & Sharat Singh. (2012) Development and validation of a homogeneous mobility shift assay for the measurement of infliximab and antibodies-to-infliximab levels in patient serum. Journal of Immunological Methods 382:1-2, pages 177-188.
Crossref
Crossref
Sandeep Kumar, Mark A. Mitchell, Bonita Rup & Satish K. Singh. (2012) Relationship Between Potential Aggregation-Prone Regions and HLA-DR-Binding T-Cell Immune Epitopes: Implications for Rational Design of Novel and Follow-on Therapeutic Antibodies. Journal of Pharmaceutical Sciences 101:8, pages 2686-2701.
Crossref
Crossref
Dimitry M. Danilenko & Hong Wang. (2012) The Yin and Yang of Immunomodulatory Biologics: Assessing the Delicate Balance between Benefit and Risk. Toxicologic Pathology 40:2, pages 272-287.
Crossref
Crossref
L. Guilleminault, E. Lemarié & N. Heuzé-Vourc’h. (2012) Monoclonal Antibodies: An Emerging Class of Therapeutics in Non Small Cell Lung Cancer. Journal of Cancer Therapy 03:06, pages 1170-1190.
Crossref
Crossref
. 2012. Klinische Immunologie. Klinische Immunologie
e1
e80
.
Donna J. Clemons, Vince Meador, Gerhard F. Weinbauer & G. Alex Wakefield. 2012. Nonhuman Primates in Biomedical Research. Nonhuman Primates in Biomedical Research
493
510
.
Lolke de Haan. 2012. Development of Antibody-Based Therapeutics. Development of Antibody-Based Therapeutics
255
284
.
Christine GalustianAnnapurna VyakarnamOussama ElhageOliver HickmanProkar DasguptaRichard A. Smith. (2011) Immunotherapy of prostate cancer: identification of new treatments and targets for therapy, and role of WAP domain-containing proteins. Biochemical Society Transactions 39:5, pages 1433-1436.
Crossref
Crossref
Paul Chamberlain. (2011) Pre-clinical strategies and safety issues in developing therapeutic monoclonal antibodies. New Biotechnology 28:5, pages 481-488.
Crossref
Crossref
Susan Kirshner. 2011. Detection and Quantification of Antibodies to Biopharmaceuticals. Detection and Quantification of Antibodies to Biopharmaceuticals
13
35
.
Alessandra Vultaggio, Enrico Maggi & Andrea Matucci. (2011) Immediate adverse reactions to biologicals: from pathogenic mechanisms to prophylactic management. Current Opinion in Allergy & Clinical Immunology 11:3, pages 262-268.
Crossref
Crossref
Paul Baldrick. (2011) Safety evaluation of biological drugs: What are toxicology studies in primates telling us?. Regulatory Toxicology and Pharmacology 59:2, pages 227-236.
Crossref
Crossref
Chenxuan Wu, Hongxing Guo, Yijun Wang, Yingtang Gao, Zhengyan Zhu & Zhi Du. (2011) Extracellular domain of human 4-1BBL enhanced the function of cytotoxic T-lymphocyte induced by dendritic cell. Cellular Immunology 271:1, pages 118-123.
Crossref
Crossref
LaRonda L. Morford, Christopher J. Bowman, Diann L. Blanset, Ingrid B. Bøgh, Gary J. Chellman, Wendy G. Halpern, Gerhard F. Weinbauer & Timothy P. Coogan. (2011) Preclinical safety evaluations supporting pediatric drug development with biopharmaceuticals: strategy, challenges, current practices. Birth Defects Research Part B: Developmental and Reproductive Toxicology, pages n/a-n/a.
Crossref
Crossref